Aspire-Lakewood Holdings ASBP
NASDAQ ASBP
$8.75 -0.23 (-2.56%)
At close: Oct 23, 2026 · 4:00 PM EDT

Aspire Biopharma Holdings (ASBP) Gross Profit (2025 - 2026)

Updated

Aspire Biopharma Holdings' Gross Profit came in at -$30,086 for Q2 2026.

Analysis

Aspire Biopharma Holdings (ASBP) Gross Profit (2025 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Aspire Biopharma Holdings reported Gross Profit of -$24,452; for FY2025, it came in at -$116.00.

  • Business Quant data shows ASBP's Gross Profit at $5,750 (Q1 2026), -$1,000 (Q4 2025) and $884.00 (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn
10 Aspire-Lakewood Holdings 65.71 Mn 44.73 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -30,086.00
Mar 31, 2026 5,750.00
Dec 31, 2025 -1,000.00
Sep 30, 2025 884.00
API Access

Aspire Biopharma Holdings Gross Profit API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gross-profit&ticker=ASBP&period=max&api_key=YOUR_API_KEY